RICHMOND, VA--(Marketwired - September 19, 2017) - The United States Food and Drug Administration (FDA) has granted clearance to ALR Technologies Inc. (ALRT) for an innovative insulin dose adjustment ...

Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...

Patients with diabetes who use Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems can now better manage their blood glucose levels with a new method for leveraging the trend arrows ...

The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ...

The FDA has cleared Glooko's Mobile Insulin Dosing System. Glooko's new system calculates long-acting insulin dosages and sends Type 2 diabetes patients reminders on their cellphones. Long-acting ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults receiving once-weekly semaglutide 1 mg had a ...

Basaglar (insulin glargine) is a brand-name drug that’s used to help manage blood sugar levels in certain people. The drug comes as a liquid solution that’s injected under your skin. It’s usually ...

Insulin dosage is an ongoing area of interest among digital health companies. Initiating and increasing insulin dosages represent some of the greatest challenges to help Type 2 diabetes patients ...

A NIH-sponsored double-blinded, randomized clinical trial entitled Action to Control Cardiovascular Risk in Diabetes (ACCORD study) came to a halt seven years ago after patients receiving more ...

(HealthDay News) — In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, insulin dose is not associated with cardiovascular (CV) death after adjustment for baseline covariates, ...